These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cutaneous zygomycosis caused by Cunninghamella bertholletiae in a patient with chronic myelogenous leukemia in blast crisis. Motohashi K; Ito S; Hagihara M; Maruta A; Ishigatsubo Y; Kanamori H Am J Hematol; 2009 Jul; 84(7):447-8. PubMed ID: 19021120 [No Abstract] [Full Text] [Related]
24. Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib. Woo SM; Huh CH; Park KC; Youn SW J Dermatol; 2007 Oct; 34(10):724-6. PubMed ID: 17908148 [No Abstract] [Full Text] [Related]
26. Spleenic abscess in a case of chronic myeloid leukemia. Somalwar AM; Jalgaonkar PD J Assoc Physicians India; 1996 Oct; 44(10):721-2. PubMed ID: 9251346 [No Abstract] [Full Text] [Related]
27. Demyelination in the brain as a paraneoplastic disorder: candidates include some cases of leukemia and non-Hodgkin's lymphoma. Jaster JH; Niell HB; Dohan FC; Smith TW Ann Hematol; 2003 Nov; 82(11):714-5. PubMed ID: 12961034 [No Abstract] [Full Text] [Related]
28. Childhood chronic myeloid leukemia with celiac disease. Singhal M; Makharia G; Bakhshi S Pediatr Blood Cancer; 2010 Jan; 54(1):177. PubMed ID: 19731332 [No Abstract] [Full Text] [Related]
29. Idiopathic intracranial hypertension as the initial manifestation of chronic myeloid leukemia: letter to editor. Pavithran K; Thomas M Neurol India; 2002 Jun; 50(2):230. PubMed ID: 12134204 [No Abstract] [Full Text] [Related]
30. First case report of sepsis caused by Mycobacterium wolinskyi in chronic myelogenous leukemia. Ohno T; Kishimoto W; Chihara D; Sakamoto T; Arimoto-Miyamoto K; Takeoka T; Tsuji M; Kida K; Ohkusu K; Ezaki T Diagn Microbiol Infect Dis; 2008 Dec; 62(4):433-6. PubMed ID: 18929459 [TBL] [Abstract][Full Text] [Related]
31. Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. Tiribelli M; Colatutto A; Marin L; Barbina G; Qualizza U; Damiani D; Toffoletti E; Medeot M; Candoni A; Tonutti E; Sala P; Fanin R Am J Hematol; 2008 Jun; 83(6):517-8. PubMed ID: 18306359 [No Abstract] [Full Text] [Related]
35. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases. Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300 [TBL] [Abstract][Full Text] [Related]
36. Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia. Campiotti L; Grandi AM; Biotti MG; Ultori C; Solbiati F; Codari R; Venco A Am J Hematol; 2007 Mar; 82(3):231-3. PubMed ID: 17022045 [TBL] [Abstract][Full Text] [Related]
37. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22. Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834 [TBL] [Abstract][Full Text] [Related]
38. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36). Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950 [TBL] [Abstract][Full Text] [Related]
39. Re: Chronic myeloid leukaemia presenting as priapism in children: need for multidisciplinary approach. Nabi G; Dogra PN East Afr Med J; 2000 Oct; 77(10):576. PubMed ID: 12862132 [No Abstract] [Full Text] [Related]
40. Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib. Franceschino A; Tornaghi L; Benemacher V; Assouline S; Gambacorti-Passerini C Haematologica; 2008 Feb; 93(2):317-8. PubMed ID: 18245661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]